TCL Archive Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone April 10, 1987
TCL Archive Vaccine Prevented Cervical Pre-Cancers, Non-Invasive Cancers In Phase III Trial October 28, 2005